Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D07RGW
|
||||
Former ID |
DAP000508
|
||||
Drug Name |
Mephenytoin
|
||||
Synonyms |
Epiazin; Epilan; Fenantoin; Insulton; Mefenetoin; Mefenitoina; Mephenetoinum; Mephentoin; Mephenytoine; Mephenytoinum; Mesantoin; Mesdontoin; Mesontoin; Methoin; Methylphenetoin; Metydan; Phenantoin; Phenylethylmethylhydantoin; Sacerno; Sedantional; Sedantoin; Sedantoinal; Triantoin; Ydantoin; Methyl Phenetoin; Methyl hydantoin; MU2276000; Gerot-epilan; L-Mephenytoin; Mefenitoina [INN-Spanish]; Mephenytoin [USAN:INN]; Mephenytoine [INN-French]; Mephenytoinum [INN-Latin]; Mesantoin (TN); Phenetoin, Methyl;Mephenytoin (USP/INN); L-3-Methyl-5-ethyl-5-phenylhydantoin; (+-)-5-Ethyl-3-methyl-5-phenylhydantoin; (+-)-Mephenytoin; (-)-5-Ethyl-3-methyl-5-phenylhydantoin; 3-Ethylnirvanol; 3-Methyl-5, 5-ethylphenylhydantoin; 3-Methyl-5,5-ethylphenylhydantoin; 3-Methyl-5,5-phenylethylhydantoin; 3-Methyl-5-ethyl-5-phenylh; 3-Methyl-5-ethyl-5-phenylhydantoin; 5 Ethyl 3 Methyl 5 Phenylhydantoin; 5-Ethyl-3-methyl-5-phenyl-2,4(3H,5H)-imidazoledione; 5-Ethyl-3-methyl-5-phenyl-2,4-imidazolidinedione; 5-Ethyl-3-methyl-5-phenylhydantoin; 5-Ethyl-3-methyl-5-phenylimidazolidin-2,4-dione; 5-Ethyl-5-fenyl-3-methylhydantoin; 5-Ethyl-5-fenyl-3-methylhydantoin [Czech]; 5-ethyl-3-methyl-5-phenylimidazolidine-2,4-dione
|
||||
Drug Type |
Small molecular drug
|
||||
Therapeutic Class |
Anticonvulsants
|
||||
Company |
Norvatis Phamaceuticals Corporation
|
||||
Structure |
Download2D MOL |
||||
Formula |
C12H14N2O2
|
||||
InChI |
InChI=1S/C12H14N2O2/c1-3-12(9-7-5-4-6-8-9)10(15)14(2)11(16)13-12/h4-8H,3H2,1-2H3,(H,13,16)
|
||||
InChIKey |
GMHKMTDVRCWUDX-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 50-12-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
92176, 220439, 4359670, 7847441, 7872066, 8150040, 8152547, 10524271, 11336112, 11361351, 11364388, 11366950, 11369512, 11374646, 11377674, 11462323, 11467136, 11468256, 11486824, 11492908, 11495308, 14773490, 29217682, 29223171, 46508677, 47291207, 47662362, 47959838, 47959839, 48035210, 48185062, 48416216, 49698809, 49703443, 49977224, 49977225, 50111722, 53789258, 56463168, 57322121, 79894519, 85788588, 92126062, 92308878, 92714624, 99302025, 103224438, 103914622, 104305314, 121363733
|
||||
SuperDrug ATC ID |
N03AB04
|
||||
SuperDrug CAS ID |
cas=000050124
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel protein type 5 subunit alpha | Target Info | Blocker | [537516] | |
KEGG Pathway | Adrenergic signaling in cardiomyocytes | ||||
PathWhiz Pathway | Muscle/Heart Contraction | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References | |||||
Ref 538388 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (NDA) 006008. | ||||
Ref 542238 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7223). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.